196
Participants
Start Date
September 30, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
ESA
Participants will continue to receive their ESA treatment, as per physician's discretion. The study protocol does not specify any particular ESA drug.
Satisfaction Survey Questionnaire
Each participant will be interviewed to complete treatment satisfaction questionnaire survey at baseline and at 6-month follow-up visit.
Kaplan Medical Center; Nephrology and Hypertension Services, Rehovot
Clalit- New Savyon Clinic, Ganey Tikva
Clalit - Diabetic HaMoshava South Clinic, Jerusalem
Clalit Carmiel, Karmiel
Clalit - Professional Clinic, Zvulun, Kiryat Bialik
Clalit Ben-Gurion, Naẕerat ‘Illit
Clalit- Migdal HaMea Clinic, Tel Aviv, Tel Aviv
Hoffmann-La Roche
INDUSTRY